retrospect
comparison
convalesc
plasma
continu
highdos
methylprednisolon
treatment
sar
patient
depart
medicin
therapeut
paediatr
anatom
cellular
patholog
microbiolog
chines
univers
hong
kong
hong
kong
treatment
sever
acut
respiratori
syndrom
sar
experiment
effect
ribavirinsteroid
therapi
unclear
forti
sar
patient
progress
diseas
ribavirin
treatment
g
puls
methylprednisolon
given
either
convalesc
plasma
n
puls
methylprednisolon
n
retrospect
nonrandomis
studi
good
clinic
outcom
defin
discharg
day
follow
onset
symptom
convalesc
plasma
obtain
recov
patient
inform
consent
patient
plasma
group
shorter
hospit
stay
p
lower
mortal
p
compar
group
immedi
advers
effect
observ
follow
plasma
infus
highli
infecti
respiratori
ill
caus
novel
coronaviru
treatment
mainli
empir
princ
wale
hospit
ribavirin
steroid
use
firstlin
treatment
suppress
viral
replic
minimis
autoimmun
pneumon
c
patient
ribavirinsteroid
combin
associ
recoveri
howev
great
debat
whether
ribavirin
effect
coronaviru
well
concern
side
effect
highdos
steroid
patient
persist
fever
radiograph
progress
hypoxaemia
despit
receiv
g
methylprednisolon
respond
poorli
cours
highdos
steroid
altern
therapi
need
postul
convalesc
plasma
recov
sar
patient
would
carri
antibodi
coronaviru
might
suppress
viraemia
retrospect
comparison
studi
perform
sar
patient
admit
march
april
patient
treat
empir
ribavirin
methylprednisoln
inclus
criteria
follow
sar
diagnos
accord
center
diseas
control
guidelin
clinic
radiograph
deterior
despit
ribavirin
three
dose
mg
puls
methylprednisolon
patient
receiv
intraven
immunoglobulin
pentaglobulin
proteas
inhibitor
fewer
three
dose
methylprednisolon
exclud
patient
studi
given
either
convalesc
plasma
plasma
group
puls
methylprednisolon
steroid
group
discret
attend
clinician
accord
avail
convalesc
plasma
potenti
benefit
side
effect
convalesc
plasma
explain
care
patient
famili
patient
plasma
group
could
receiv
puls
steroid
condit
worsen
plasma
therapi
class
plasma
therapi
failur
similarli
patient
steroid
arm
deterior
puls
methylprednisolon
could
receiv
convalesc
plasma
class
steroid
therapi
failur
follow
inform
consent
convalesc
plasma
obtain
patient
recov
sar
seroneg
hepat
b
hepat
c
hiv
syphili
serum
donor
seroposit
coronaviru
titr
apharesi
perform
cs
cell
separ
baxter
deerfield
il
usa
ml
plasma
obtain
donor
base
experi
ebola
viru
ml
convalesc
plasma
use
treat
recruit
patient
good
respons
therapi
defin
discharg
day
follow
onset
sar
symptom
poor
respons
defin
death
hospitalis
beyond
day
discharg
criteria
accord
hospit
author
guidelin
follow
afebril
consecut
day
improv
previous
abnorm
laboratori
test
white
cell
count
platelet
count
creatinin
phosphokinas
lactat
dehydrogenas
liver
function
test
c
reactiv
protein
radiograph
improv
period
least
day
follow
onset
ill
sinc
evid
coronaviru
still
detect
stool
recov
patient
week
chart
review
data
enter
independ
first
two
author
treatment
outcom
age
lactat
dehydrogenas
level
admiss
compar
patient
plasma
group
steroid
group
numer
data
compar
independ
sampl
student
ttest
categor
data
compar
fisher
exact
test
differ
consid
signific
level
p
nineteen
patient
receiv
convalesc
plasma
three
dose
puls
methylprednisolon
plasma
group
two
also
receiv
addit
puls
steroid
nine
patient
steroid
group
n
given
convalesc
plasma
subsequ
four
eight
dose
puls
methylprednisolon
age
sex
lactat
dehydrogenas
level
admiss
compar
two
group
tabl
plasma
group
patient
discharg
day
compar
steroid
group
p
tabl
five
peopl
die
steroid
group
patient
receiv
steroid
compar
death
plasma
group
p
nine
patient
steroid
group
receiv
viral
ill
viraemia
peak
first
week
infect
patient
develop
primari
immun
respons
day
follow
viru
clearanc
therefor
convalesc
plasma
effect
given
earli
cours
diseas
sar
viral
load
also
peak
first
week
might
explain
lack
clinic
effect
convalesc
plasma
given
day
sever
limit
studi
first
randomis
studi
steroid
group
coexist
morbid
howev
analysi
repeat
exclud
patient
comorbid
ill
group
differ
clinic
outcom
remain
statist
signific
p
second
amount
antibodi
given
patient
standardis
could
contribut
variabl
clinic
outcom
patient
receiv
convalesc
plasma
final
arguabl
whether
ribavirinsteroid
combin
effect
sar
patient
poorer
outcom
continu
highdos
methylprednisolon
group
might
caus
simpli
deleteri
effect
steroid
howev
fungal
opportunist
infect
observ
patient
summari
preliminari
data
show
convalesc
plasma
therapi
associ
favour
outcom
sar
patient
deterior
despit
ribavirin
highdos
steroid
therapi
continu
highdos
methylprednisolon
larger
randomis
studi
requir
confirm
preliminari
result
